These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 38965978)

  • 1. Women's preferences for HIV prevention service delivery in pharmacies during pregnancy in Western Kenya: a discrete choice experiment.
    Mugambi ML; Odhiambo BO; Dollah A; Marwa MM; Nyakina J; Kinuthia J; Baeten JM; Weiner BJ; John-Stewart G; Barnabas RV; Hauber B
    J Int AIDS Soc; 2024 Jul; 27 Suppl 1(Suppl 1):e26301. PubMed ID: 38965978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low selection of HIV PrEP refills at private pharmacies among clients who initiated PrEP at public clinics: findings from a mixed-methods study in Kenya.
    Ortblad KF; Kuo AP; Mogere P; Roche SD; Kiptinness C; Wairimu N; Gakuo S; Baeten JM; Ngure K
    BMC Health Serv Res; 2024 May; 24(1):618. PubMed ID: 38730398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing HIV pre-exposure prophylaxis outcomes among Kenyan adolescent girls and young women with a novel pharmacy-based PrEP delivery platform: protocol for a cluster-randomized controlled trial.
    Lagat HK; Pintye J; Harrington E; Houck S; Kwena Z; Lenn M; Mogaka F; Momanyi V; Mugambi M; Nyerere B; Odoyo J; Omollo V; Ortblad KF; Rota G; Sharma M; Bukusi EA
    Trials; 2024 Jun; 25(1):394. PubMed ID: 38890744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and evaluation of strategies to implement HIV prevention interventions for pregnant women in community pharmacy settings in western Kenya: a mixed-methods study protocol.
    Mugambi ML; Baeten JM; Kinuthia J; Hauber B; Weiner BJ; John-Stewart G; Barnabas RV
    BMJ Open; 2021 Dec; 11(12):e052311. PubMed ID: 34911715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Young Women's Stated Preferences for Biomedical HIV Prevention: Results of a Discrete Choice Experiment in Kenya and South Africa.
    Minnis AM; Browne EN; Boeri M; Agot K; van der Straten A; Ahmed K; Weinrib R; Mansfield C
    J Acquir Immune Defic Syndr; 2019 Apr; 80(4):394-403. PubMed ID: 30633040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating preexposure prophylaxis delivery in routine family planning clinics: A feasibility programmatic evaluation in Kenya.
    Mugwanya KK; Pintye J; Kinuthia J; Abuna F; Lagat H; Begnel ER; Dettinger JC; John-Stewart G; Baeten JM;
    PLoS Med; 2019 Sep; 16(9):e1002885. PubMed ID: 31479452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV pre-exposure prophylaxis programme preferences among sexually active HIV-negative transgender and gender diverse adults in the United States: a conjoint analysis.
    Watson DL; Listerud L; Drab RA; Lin WY; Momplaisir FM; Bauermeister JA
    J Int AIDS Soc; 2024 Feb; 27(2):e26211. PubMed ID: 38332521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferences for long-acting Pre-Exposure Prophylaxis (PrEP) for HIV prevention among South African youth: results of a discrete choice experiment.
    Minnis AM; Atujuna M; Browne EN; Ndwayana S; Hartmann M; Sindelo S; Ngcwayi N; Boeri M; Mansfield C; Bekker LG; Montgomery ET
    J Int AIDS Soc; 2020 Jun; 23(6):e25528. PubMed ID: 32544303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing preferences for HIV pre-exposure prophylaxis (PrEP) delivery services via online pharmacies in Kenya: protocol for a discrete choice experiment.
    Chen Y; Saldarriaga EM; Montano MA; Ngure K; Thuo N; Kiptinness C; Rafferty M; Terris-Prestholt F; Stergachis A; Mugambi ML; Ortblad KF; Sharma M
    BMJ Open; 2023 Apr; 13(4):e069195. PubMed ID: 37012008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring the performance of HIV self-testing at private pharmacies in Kenya: a cross-sectional study.
    Ortblad KF; Kwach B; Zhang S; Asewe M; Ongwen PA; Malen RC; Harkey K; Odoyo J; Gathii P; Rota G; Sharma M; Were DK; Ngure K; Omollo V; Bukusi EA
    J Int AIDS Soc; 2023 Oct; 26(10):e26177. PubMed ID: 37848405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Fidelity of a Pharmacy-Based Oral HIV Pre-Exposure Prophylaxis Delivery Model in Kenya.
    Omollo V; Asewe M; Mogere P; Maina G; Kuo AP; Odoyo J; Oware K; Baeten JM; Kohler P; Owens T; Bukusi EA; Ngure K; Ortblad KF
    J Acquir Immune Defic Syndr; 2023 Aug; 93(5):379-386. PubMed ID: 37079900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stand-alone model for delivery of oral HIV pre-exposure prophylaxis in Kenya: a single-arm, prospective pilot evaluation.
    Ortblad KF; Mogere P; Omollo V; Kuo AP; Asewe M; Gakuo S; Roche S; Mugambi M; Mugambi ML; Stergachis A; Odoyo J; Bukusi EA; Ngure K; Baeten JM
    J Int AIDS Soc; 2023 Jun; 26(6):e26131. PubMed ID: 37306128
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Vera M; Bukusi E; Achieng P; Aketch H; Araka E; Baeten JM; Beima-Sofie K; John-Stewart G; Kohler PK; Mugambi ML; Nyerere B; Odoyo J; Omom C; Omondi C; Ortblad KF; Pintye J
    J Int Assoc Provid AIDS Care; 2023; 22():23259582231215882. PubMed ID: 37997351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Awareness, Yet Low Uptake, of Pre-Exposure Prophylaxis Among Adolescent Girls and Young Women Within Family Planning Clinics in Kenya.
    Sila J; Larsen AM; Kinuthia J; Owiti G; Abuna F; Kohler PK; John-Stewart G; Pintye J
    AIDS Patient Care STDS; 2020 Aug; 34(8):336-343. PubMed ID: 32757980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferences for Long-Acting PrEP Products Among Women and Girls: A Quantitative Survey and Discrete Choice Experiment in Eswatini, Kenya, and South Africa.
    Little KM; Hanif H; Anderson SM; Clark MR; Gustafson K; Doncel GF
    AIDS Behav; 2024 Mar; 28(3):936-950. PubMed ID: 37971614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. My Way: development and preliminary evaluation of a novel delivery system for PrEP and other sexual health needs of young women in Western Kenya.
    Haberer JE; Oware K; Juma L; Nyerere B; Momanyi V; Odoyo J; Garrison L; Bhagat J; Musinguzi N; Baeten JM; Siegler A; Bukusi EA
    J Int AIDS Soc; 2024 Feb; 27(2):e26217. PubMed ID: 38379132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preference for novel biomedical HIV pre-exposure prophylaxis methods among adolescent girls and young women in Kampala, Uganda: a mixed methods study.
    Mayanja Y; Kayesu I; Kamacooko O; Lunkuse JF; Muturi-Kioi V; Price M; Kosidou K; Ekström AM
    Front Public Health; 2024; 12():1369256. PubMed ID: 38846614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectiveness, feasibility and acceptability of HIV service delivery at private pharmacies in sub-Saharan Africa: a scoping review.
    Kuo AP; Roche SD; Mugambi ML; Pintye J; Baeten JM; Bukusi E; Ngure K; Stergachis A; Ortblad KF
    J Int AIDS Soc; 2022 Oct; 25(10):e26027. PubMed ID: 36285619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Willingness and preferences for long-acting injectable PrEP among US men who have sex with men: a discrete choice experiment.
    Cole SW; Glick JL; Campoamor NB; Sanchez TH; Sarkar S; Vannappagari V; Rinehart A; Rawlings K; Sullivan PS; Bridges JFP
    BMJ Open; 2024 Apr; 14(4):e083837. PubMed ID: 38653510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of a care pathway for pharmacy-based PrEP delivery in Kenya: results from a collaborative stakeholder consultation.
    Ortblad KF; Mogere P; Roche S; Kamolloh K; Odoyo J; Irungu E; Mugo NR; Pintye J; Baeten JM; Bukusi E; Ngure K;
    BMC Health Serv Res; 2020 Nov; 20(1):1034. PubMed ID: 33176785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.